Ensysce Biosciences clinical trials we track

Check company identity source

Phase 3 1 trial

TrialDrugs studiedStatusPrimary completion
PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)NCT06602271PF614 capsuleRecruiting2026-08Estimated

Phase 2 1 trial

TrialDrugs studiedStatusPrimary completion
Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)NCT06629402PF614Completed2023-11-14Actual

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 3 fields changed

Planned enrollment increased by 20 participants

Before: 300 participants (planned). After: 320 participants (planned).

Primary completion date changed

Before: Mar 2026. After: Aug 2026.

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source